# Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections

> **NCT07025044** · — · RECRUITING · sponsor: **Alexis Dieter** · enrollment: 40 (estimated)

## Conditions studied

- Overactive Bladder (OAB)
- Urge Incontinence

## Interventions

- **DRUG:** onabotulinum toxin type a

## Key facts

- **NCT ID:** NCT07025044
- **Lead sponsor:** Alexis Dieter
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07025044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07025044, "Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07025044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*